Clearside’s wet AMD drug-device combo shines in Phase IIb study
Clearside is now looking at a Phase III trial as it plans to meet with the FDA early next year to discuss the new Phase IIb topline results.
10 October 2024
10 October 2024
Clearside is now looking at a Phase III trial as it plans to meet with the FDA early next year to discuss the new Phase IIb topline results.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.